https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3AAnti-obesity_medication%2F23%2FenTranslations:Anti-obesity medication/23/en - Revision history2026-09-15T03:48:43ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:Anti-obesity_medication/23/en&diff=125279&oldid=prevFuzzyBot: Importing a new version from external source2024-03-07T09:16:04Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>==Safety and side effects==<br />
Some anti-obesity medications can have severe, even, lethal side effects, [[fen-phen]] being a famous example. Fen-phen was reported through the FDA to cause abnormal echocardiograms, heart valve problems, and rare valvular diseases. Out of 25 anti-obesity medications withdrawn from the market between 1964 and 2009, 23 acted by altering the functions of chemical [[neurotransmitters]] in the brain. The most common side effects of these drugs that led to withdrawals were mental disturbances, cardiac side effects, and [[Substance abuse|drug abuse]] or [[drug dependence]]. Deaths were associated with seven products. [[Ephedra (medicine)|Ephedra]] was removed from the US market in 2004 over concerns that it raises blood pressure and could lead to strokes and death.</div>FuzzyBot